Pre- and Apnoeic Oxygenation for RSI in ED
Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · Jan 4, 2018
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
Maintaining adequate oxygenation during rapid sequence intubation (RSI) is imperative to prevent peri-intubation adverse events that can lead to increased duration of hospital and intensive care unit stay, or prolonged vegetative state requiring long-term institutionalisation.
Preliminary data from our emergency department (ED) airway registry revealed that 15% of patients experienced desaturation during intubation despite employing current best practices during RSI. In this multicentre randomised controlled trial in the ED, we aim to test the hypothesis that use of humidified high flow ox...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients aged 21 years and above, who require RSI due to medical, surgical and traumatic conditions, in the Emergency Departments of NUH and Ng Teng Fong General Hospital (NTFGH)
- Exclusion Criteria:
- • Patients with "do-not-resuscitate" orders
- • Crash, awake or delayed sequence intubations
- • Patients requiring non-invasive positive pressure ventilation
- • Cardiac arrest
- • Clinical suspicion or confirmed diagnosis of base of skull fractures or severe facial trauma that precludes nasal cannula placement
- • Vulnerable patient populations (e.g. pregnant women, prisoners)
About National University Hospital, Singapore
National University Hospital (NUH) in Singapore is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, NUH emphasizes a multidisciplinary approach, integrating cutting-edge medical research with high-quality patient care. The hospital collaborates with various stakeholders, including academic institutions and industry partners, to explore new therapies and improve treatment outcomes across a wide range of medical disciplines. Committed to ethical standards and patient safety, NUH plays a pivotal role in shaping the future of medicine in Singapore and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Mui Teng Chua, MBBS, MPH
Principal Investigator
National University Hospital, Singapore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials